| Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ... The lancet oncology 10 (1), 35-43, 2009 | 2253 | 2009 |
| Prospective validation of the Barcelona Clinic Liver Cancer staging system U Cillo, A Vitale, F Grigoletto, F Farinati, A Brolese, G Zanus, D Neri, ... Journal of hepatology 44 (4), 723-731, 2006 | 507 | 2006 |
| Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma U Cillo, A Vitale, M Bassanello, P Boccagni, A Brolese, G Zanus, P Burra, ... Annals of Surgery 239 (2), 150-159, 2004 | 374 | 2004 |
| The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? U Cillo, M Bassanello, A Vitale, FA Grigoletto, P Burra, S Fagiuoli, ... Journal of hepatology 40 (1), 124-131, 2004 | 250 | 2004 |
| Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ... Journal of hepatology 62 (3), 617-624, 2015 | 230 | 2015 |
| Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC A Notarpaolo, R Layese, P Magistri, M Gambato, M Colledan, G Magini, ... Journal of hepatology 66 (3), 552-559, 2017 | 221 | 2017 |
| Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study A Vitale, RR Morales, G Zanus, F Farinati, P Burra, P Angeli, AC Frigo, ... The lancet oncology 12 (7), 654-662, 2011 | 183 | 2011 |
| Can hepatic resection provide a long‐term cure for patients with intrahepatic cholangiocarcinoma? G Spolverato, A Vitale, A Cucchetti, I Popescu, HP Marques, L Aldrighetti, ... Cancer 121 (22), 3998-4006, 2015 | 175 | 2015 |
| Personalized treatment of patients with very early hepatocellular carcinoma A Vitale, M Peck-Radosavljevic, EG Giannini, E Vibert, W Sieghart, ... Journal of hepatology 66 (2), 412-423, 2017 | 156 | 2017 |
| Consensus conference on TIPS management: techniques, indications, contraindications S Fagiuoli, R Bruno, WD Venon, F Schepis, F Vizzutti, P Toniutto, ... Digestive and Liver Disease 49 (2), 121-137, 2017 | 152 | 2017 |
| Development and validation of a new prognostic system for patients with hepatocellular carcinoma F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ... PLoS medicine 13 (4), e1002006, 2016 | 141 | 2016 |
| Treatment of hepatocellular carcinoma in the precision medicine era: from treatment stage migration to therapeutic hierarchy A Vitale, F Trevisani, F Farinati, U Cillo Hepatology 72 (6), 2206-2218, 2020 | 135 | 2020 |
| Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up‐to‐seven criteria F D'Amico, M Schwartz, A Vitale, P Tabrizian, S Roayaie, S Thung, ... Liver transplantation 15 (10), 1278-1287, 2009 | 132 | 2009 |
| Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria U Cillo, A Vitale, F Grigoletto, E Gringeri, F D'amico, M Valmasoni, ... American Journal of Transplantation 7 (4), 972-981, 2007 | 128 | 2007 |
| Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety A Vitale, ML Volk, D Pastorelli, S Lonardi, F Farinati, P Burra, P Angeli, ... Hepatology 51 (1), 165-173, 2010 | 126 | 2010 |
| A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation A Cavallari, U Cillo, B Nardo, F Filipponi, E Gringeri, R Montalti, F Vistoli, ... Liver Transplantation 9 (8), 814-821, 2003 | 120 | 2003 |
| Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA. LI. CA database A Vitale, G Svegliati-Baroni, A Ortolani, M Cucco, GV Dalla Riva, ... Gut 72 (1), 141-152, 2023 | 118 | 2023 |
| Intention‐to‐treat survival benefit of liver transplantation in patients with hepatocellular cancer Q Lai, A Vitale, S Iesari, A Finkenstedt, G Mennini, G Spoletini, ... Hepatology 66 (6), 1910-1919, 2017 | 109 | 2017 |
| A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, RR Morales, L De Carlis, ... Journal of hepatology 60 (2), 290-297, 2014 | 107 | 2014 |
| Development and validation of a comprehensive model to estimate early allograft failure among patients requiring early liver retransplant AW Avolio, A Franco, A Schlegel, Q Lai, S Meli, P Burra, D Patrono, ... JAMA surgery 155 (12), e204095-e204095, 2020 | 91 | 2020 |
Umberto CilloUnità di Chirurgia Epatobiliare e Trapianto Epatico, Università degli Studi di Padovaכתובת אימייל מאומתת בדומיין unipd.it